
Electromed ELMD
$ 24.12
-1.19%
Quarterly report 2025-Q4
added 02-10-2026
Electromed Interest Expense 2011-2026 | ELMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Electromed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 78 K | 25 K | 27 K | 121 K | 90.7 K | 19.9 K | -49.9 K | -66.8 K | 85.7 K | 79 K | 117 K | 169 K | 191 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 191 K | -66.8 K | 68.2 K |
Quarterly Interest Expense Electromed
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 152 K | 195 K | - | 120 K | 96 K | 77 K | - | 26 K | 7 K | 4 K | 11 K | 6 K | 6 K | 9 K | 15 K | 10 K | 9.71 K | 9 K | 19 K | 9.28 K | 37.1 K | 40 K | 37.1 K | 40 K | 16.5 K | 13.5 K | 16.5 K | 13.5 K | -4.89 K | -4.2 K | -4.89 K | -4.2 K | -15.6 K | -16.7 K | -15.6 K | -16.7 K | -17.9 K | 20.2 K | -17.9 K | 20.4 K | 24.7 K | 20.5 K | 45.1 K | 20.5 K | 19.5 K | 15.2 K | 19.5 K | 15.2 K | 25.8 K | 36.7 K | 25.8 K | 36.7 K | 43.6 K | 43.9 K | 43.6 K | 43.9 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 195 K | -17.9 K | 25.9 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 173.14 | -0.8 % | $ 13 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 279.25 | 0.63 % | $ 7.88 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 10.9 | -1.54 % | $ 1.64 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.17 | -0.41 % | $ 1.64 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.3 | -1.79 % | $ 124 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 37.59 | -1.03 % | $ 5.6 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 61.79 | 0.83 % | $ 91.5 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.89 | - | $ 1.15 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 8.68 | -3.12 % | $ 246 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.97 | 0.19 % | $ 375 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.33 | -4.95 % | $ 168 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 62.78 | -0.93 % | $ 3.42 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.7 | 4.4 % | $ 68.2 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 90.42 | -1.07 % | $ 12.2 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.11 | -0.96 % | $ 870 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.04 | 1.62 % | $ 360 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Myomo
MYO
|
-668 K | $ 0.69 | -1.43 % | $ 28.9 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 54.02 | -4.71 % | $ 1.59 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.74 | -0.51 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 85.11 | -1.8 % | $ 2.96 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.68 | 0.38 % | $ 122 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 77.87 | -1.62 % | $ 45.5 B |